Assessing clinicians' views: The development of the Bakirkoy Clinician Stance Questionnaire

Objective: Although there is a wide range of theoretical perspectives and clinical practices, there is no assessment tool that reveals these variations among clinicians. In this study, we presented the development process of a new measure for clinicians that assess their psychological flexibility levels, attitudes towards psychotherapy and inclination to the mechanistic approach. Method: Participants included 167 psychiatrists and psychiatry residents from all over Turkey. They completed 29 items intended to form the basis for the Bakirkoy Clinician’s Attitude Questionnaire (BCSQ). Item-total correlation and Cronbach’s alpha correlation analyses were performed to determine internal consistency. The Acceptance and Action Questionnaire-II (AAQ-II) and the Mental Illness: Clinicians’ Attitude Scale V.4 (MICA v4) were used to assess the convergent and concurrent validity of BCSQ. Results: Principal component analyses with varimax rotation were conducted to ensure construct validity and to explore subdimensions. Finally, a three-dimensional version (Clinical inflexibility, Treatment preference, Mechanistic approach) of the scale with 20 items was created. The BCSQ demonstrated good internal consistency (Cronbach’s alpha coefficient was 0.82) and transient stability. Convergent validity analyses showed that BCSQ subscales have significant relationships with higher psychological inflexibility and stigmatization levels. Conclusion: BCSQ proves to be a valuable tool for assessing changes in the level of psychological flexibility of clinicians in clinical practice, their attitudes towards psychotherapy/psychopharmacology and their view of psychopathology.

PDF

___

1. Hayes SC, Barnes-Holmes D, Wilson KG. Contextual Behavioral Science: creating a science more adequate to the challenge of the human condition. J Contextual Behav Sci 2012; 1:1-16.[CrossRef]
2. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010; 167:748-751.[CrossRef]
3. Kupfer DJ, First MB, Regier DA. A research agenda for DSM-V. First ed. Washington, DC, US: American Psychiatric Association, 2002.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Fourth ed. Washington, DC, US: American Psychiatric Association, 1994.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Fifth ed. Washington, DC, US: American Psychiatric Association, 2013. [CrossRef]
6. World Health Organization. International statistical classification of diseases and related health problems (11th Revision). Available from: https://icd.who.int/browse11/l-m/en. Accessed May 22, 2019.
7. Hayes SC, Wilson KG, Gifford E V, Follette VM, Strosahl K. Experiential avoidance and behavioral disorders: a functional dimensional approach to diagnosis and treatment. J Consult Clin Psychol 1996; 64:1152-1168. [CrossRef]
8. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 2003; 160:4-12.
9. Andersson G, Ghaderi A. Overview and analysis of the behaviourist criticism of the diagnostic and statistical manual of mental disorders (DSM). Clin Psychol 2006; 10:67-77. [CrossRef]
10. Wakefield JC. The DSM’s theory-neutral nosology is scientifically progressive: response to Follette and Houts (1996). J Consult Clin Psychol 1998; 66:846-852. [CrossRef]
11. Hayes SC, Follette WC. Can functional analysis provide a substitute for syndromal classification? Behav Assess 1992; 14:345-365.
12. Regier DA, Narrow WE, Kuhl EA, Kupfer DJ. The conceptual development of DSM-V. Am J Psychiatry 2009; 166:645-650.
13. Kinderman P, Read J, Moncrieff J, Bentall RP. Drop the language of disorder. Evid Based Ment Health 2013; 16:2-3. [CrossRef]
14. Biglan A, Hayes SC. Should the behavioral sciences become more pragmatic? the case for functional contextualism in research on human behavior. Appl Prev Psychol 1996; 5:47-57. [CrossRef]
15. Moncrieff J. The bitterest pills: the troubling story of antipsychotic drugs. First ed. UK: Palgrave Macmillan, 2013. [CrossRef]
16. Hayes SC, Nelson RO, Jarrett RB. The treatment utility of assessment: a functional approach to evaluating assessment quality. Am Psychol 1987; 42:963. [CrossRef]
17. Cromby J, Harper D, Reavey P. Psychology, mental health and distress. First ed. UK: Palgrave Macmillan, 2013. [CrossRef]
18. Johns LC, Van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev 2001; 21:1125-1141.
19. Cooke A, Kinderman P. “But what about real mental illnesses?” Alternatives to the disease model approach to “Schizophrenia.” J Humanist Psychol 2018; 58:47-71. [CrossRef]
20. Young Minds. Stigma: A review of the evidence. Young Minds. Available from: https://childhub.org/en/system/tdf/library/ attachments/stigma-review.pdf?file=1&type=node&id=24940. Acceseed June 6, 2019. ]
21. Read J, Haslam N, Sayce L, Davies E. Prejudice and schizophrenia: a review of the “mental illness is an illness like any other” approach. Acta Psychiatr Scand 2006; 114:303-318.[CrossRef]
22. Hammer T. Mental health and social exclusion among unemployed youth in Scandinavia. A comparative study. Int J Soc Welf 2000; 9:53-63. [CrossRef]
23. Bennett L, Thirlaway K, Murray AJ. The stigmatising implications of presenting schizophrenia as a genetic disease. J Genet Couns 2008; 17:550-559. [CrossRef]
24. Dickerson FB, Sommerville J, Origoni AE, Ringel NB, Parente F. Experiences of stigma among outpatients with schizophrenia. Schizophr Bull 2002; 28:143-155. [CrossRef]
25. Ozmen E, Taskin EO. The influence of attitudes toward mental disorders to mental health services. Psikiyatri Psikoloji Psikofarmakoloji Dergisi 2004; 12:83-92. [Turkish]
26. Gabba6ard GO, Kay J. The fate of integrated treatment: whatever happened to the biopsychosocial psychiatrist? Am J Psychiatr 2001; 158:1956-1963. [CrossRef]
27. Follette WC, Houts AC. Models of scientific progress and the role of theory in taxonomy development: a case study of the DSM. J Consult Clin Psychol 1996; 64:1120-1132.[CrossRef]
28. Weissman M, Cuijpers P. Psychotherapy over the last four decades. Harv Rev Psychiatry 2017; 25:155-158. [CrossRef]
29. Morrison AP, Turkington D, Pyle M, Spencer H, Brabban A, Dunn G, et al. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: A singleblind randomised controlled trial. Lancet 2014; 383:1395-1403.
30. Morrison AP, Hutton P, Shiers D, Turkington D. Antipsychotics: is it time to introduce patient choice? Br J Psychiatry 2012; 201:83-84. [CrossRef]
31. Allan CA. Response to the American Psychiatric Association: DSM-5 Development. British Psychological Society. Available from: https://dxrevisionwatch.files.wordpress.com/2012/02/ dsm-5-2011-bps-response.pdf. Accessed June 10 2019.
32. Hayes, SC. Analytic goals and the varieties of scientific contextualism. In: Hayes SC, Hayes LJ, Reese HW, Sarbin TR (editors). Varieties of scientific contextualism. USA: Context Press; 1993, 11-27.
33. Corrigan PW. How clinical diagnosis might exacerbate the stigma of mental illness. Soc Work 2007; 52:31-39.[CrossRef]
34. Hayes SC, Strosahl KD, Wilson KG. Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change. New York: Guilford Press; 1999.
35. Ruiz FJ. A review of acceptance and commitment therapy (ACT) empirical evidence: correlational, experimental psychopathology, component and outcome studies. Rev Int Psicol Ter Psicol 2010; 10:125-162. [CrossRef]
36. Hayes SC, Bissett R, Roget N, Padilla M, Kohlenberg BS, Fisher G, et al. The impact of acceptance and commitment training and multicultural training on the stigmatizing attitudes and professional burnout of subAttitude abuse counselors. Behav Ther 2004; 35:821-835. [CrossRef]
37. Luoma JB, Vilardaga JP. Improving therapist psychological flexibility while training acceptance and commitment therapy: a pilot study. Cogn Behav Ther 2013; 42:1-8. [CrossRef]
38. Masuda A, Hayes SC, Fletcher LB, Seignourel PJ, Bunting K, Herbst SA, et al. Impact of acceptance and commitment therapy versus education on stigma toward people with psychological disorders. Behav Res Ther 2007; 45:2764-2772. [CrossRef]
39. Varra AA, Hayes SC, Roget N, Fisher G. A randomized control trial examining the effect of acceptance and commitment training on clinician willingness to use evidence-based pharmacotherapy. J Consult Clin Psychol 2008; 76:449-458. [CrossRef]
40. Luoma JB, Hayes SC, Twohig MP, Roget N, Fisher G, Padilla M, et al. Augmenting continuing education with psychologically focused group consultation: effects on adoption of group drug counseling. Psychotherapy (Chic) 2007; 44:463-469. [CrossRef]
41. Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, et al. Preliminary psychometric properties of the acceptance and action questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther 2011; 42:676-688. [CrossRef]
42. Gloster AT, Klotsche J, Chaker S, Hummel K V, Hoyer J. Assessing psychological flexibility: what does it add above and beyond existing constructs? Psychol Assess 2011; 23:970-982.
43. Yavuz F, Ulusoy S, Iskin M, Esen FB, Burhan HS, Karadere ME, et al. Turkish version of acceptance and action questionnaire-II (AAQ-II): a reliability and validity analysis in clinical and nonclinical samples. Bulletin of Clinical Psychopharmacology 2016; 26:397-408. [CrossRef]
44. Gabbidon J, Clement S, van Nieuwenhuizen A, Kassam A, Brohan E, Norman I, et al. Mental Illness: Clinicians’ Attitudes (MICA) scale-psychometric properties of a version for healthcare students and professionals. Psychiatry Res 2013; 206:81-87.
45. Watkins MW. Determining parallel analysis criteria. J Mod Appl Stat Methods 2006; 5:344-346. [CrossRef]
46. Bartlett MS. A note on the multiplying factors for various χ 2 approximations . J R Stat Soc Series B Stat Methodol 1954;296- 298.[CrossRef]
47. Kaiser HF. A second-generation Little Jiffy. Psychometrika 1970; 25:401-415.[CrossRef]
48. Kaiser HF, Rice J. Little Jiffy, Mark Iv. Educ Psychol Meas 1974; 34:111-117. [CrossRef]
49. Taylor SM, Dear MJ. Scaling community attitudes toward the mentally ill. Schizophr Bull 1981; 7:225-240. [CrossRef]
50. Yang LH, Link BG. Measurement of attitudes, beliefs and behaviors of mental health and mental illness. October 2015. Available from: https://sites.nationalacademies.org/cs/groups/ dbassesite/documents/webpage/dbasse_170048.pdf. Accessed February 27, 2021
51. Ersoy MA, Varan A. Reliability and validity of the Turkish version of the internalized stigma of mental illness scale. Turk J Psycihatry 2007; 18:163-171.
52. Magliano L, Marasco C, Guarneri M, Malangone C, Lacrimini G, Zanus P, et al. A new questionnaire assessing the opinions of the relatives of patients with schizophrenia on the causes and social consequences of the disorder: Reliability and validity. Eur Psychiatry 1999; 14:71-75.[CrossRef]
53. Follette VM, Batten SV. The role of emotion in psychotherapy supervision: a contextual behavioral analysis. Cogn Behav Pract 2000; 7:306-312. [CrossRef]
54. Scherr SR, Herbert JD, Forman EM. The role of therapist experiential avoidance in predicting therapist preference for exposure treatment for OCD. J Context Behav Sci 2015; 4:21-29.
55. Detre T. The future of psychiatry. Am J Psychiatry 1987; 144:621- 625. [CrossRef]
56. Sudak MD DM, Goldberg MD DA. Trends in psychotherapy training: a national survey of psychiatry residency training. Acad Psychiatry 2012; 36:369-373.[CrossRef]
57. Winston A, Been H, Serby M. Psychotherapy and psychopharmacology: different universes or an integrated future? J Psychother Integr 2005; 15:213-223. [CrossRef]
58. Bach PA, Moran DJ. ACT In Practice: Case Conceptualization. In: Acceptance and Commitment Therapy. First ed. Oakland, CA: New Harbinger Publications, 2008.
59. Mojtabai R, Olfson M. National trends in psychotherapy by office-based psychiatrists. Arch Gen Psychiatry 2008; 65:962- 970. [CrossRef]
60. Lebowitz MS, Ahn WK. Effects of biological explanations for mental disorders on clinicians' empathy. Proc Natl Acad Sci U S A 2014; 111:17786-17790. [CrossRef]
61. Ben-Zeev D, Young MA, Corrigan PW. DSM-V and the stigma of mental illness. J Ment Health 2010; 19:318-327. [CrossRef]
62. Haslam N. Dehumanization: an integrative review. Pers Soc Psychol Rev 2006; 10:252-264. [CrossRef]
63. Hayes SC, Strosahl K, Wilson KG, Bissett RT, Pistorello J, Toarmino D, et al. Measuring experiential avoidance: a preliminary test of a working model. Psychol Rec 2004; 54:553- 578. [CrossRef]
64. Masuda A, Price M, Anderson PL, Schmertz SK, Calamaras MR. The role of psychological flexibility in mental health stigma and psychological distress for the stigmatizer. J Soc Clin Psychol 2009; 28:1244-1262. [CrossRef]